Cargando…
Association of Beta-2-Microglobulin With Coronary Heart Disease and All-Cause Mortality in the United States General Population
Few prospective studies explored the association of beta-2-microglobulin (B2M) with coronary heart disease (CHD) mortality. The primary objective of this study was to examine the association of serum B2M with CHD and all-cause mortality. This is a prospective cohort study of a nationally representat...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136227/ https://www.ncbi.nlm.nih.gov/pubmed/35647083 http://dx.doi.org/10.3389/fcvm.2022.834150 |
_version_ | 1784714132385169408 |
---|---|
author | Huang, Yangxi Lin, Yufeng Zhai, Xiaobing Cheng, Long |
author_facet | Huang, Yangxi Lin, Yufeng Zhai, Xiaobing Cheng, Long |
author_sort | Huang, Yangxi |
collection | PubMed |
description | Few prospective studies explored the association of beta-2-microglobulin (B2M) with coronary heart disease (CHD) mortality. The primary objective of this study was to examine the association of serum B2M with CHD and all-cause mortality. This is a prospective cohort study of a nationally representative sample of 4,885 adults, aged 40–85 years, who participated in the National Health and Nutrition Examination Survey (NHANES III) from 1988 to 1994. The relationships between B2M and CHD and all-cause mortality were estimated using Cox proportional hazards regression models. During a median follow-up of 15.5 years, 845 CHD and 3,388 all-cause deaths occurred among 4,885 participants [2,568 women (55.7%); mean (S.D.) age, 66.4 (12.5) years], respectively. In the unadjusted model, B2M concentration was strongly linearly associated with CHD and all-cause mortality (p-trend < 0.001). After adjusting multivariable factors, a positive linear association between B2M and all-cause mortality was still observed (H.R. for Q4 vs. Q1 5.90; 95% CI: 5.31–6.57; p-trend < 0.001). In the multivariable adjustment model, B2M was significantly associated with an increased risk of CHD mortality (H.R. for Q4 vs. Q1 2.72; 95% CI: 2.07–3.57; p-trend < 0.001). In the stratified analyses, the associations of B2M with CHD and all-cause mortality varied by risk factors, such as age, smoking status, and history of hypertension. The findings suggest a significant relationship between the higher serum B2M concentration and increased risk for CHD and all-cause mortality. Further large-scale follow-up studies are also needed to validate this association. |
format | Online Article Text |
id | pubmed-9136227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91362272022-05-28 Association of Beta-2-Microglobulin With Coronary Heart Disease and All-Cause Mortality in the United States General Population Huang, Yangxi Lin, Yufeng Zhai, Xiaobing Cheng, Long Front Cardiovasc Med Cardiovascular Medicine Few prospective studies explored the association of beta-2-microglobulin (B2M) with coronary heart disease (CHD) mortality. The primary objective of this study was to examine the association of serum B2M with CHD and all-cause mortality. This is a prospective cohort study of a nationally representative sample of 4,885 adults, aged 40–85 years, who participated in the National Health and Nutrition Examination Survey (NHANES III) from 1988 to 1994. The relationships between B2M and CHD and all-cause mortality were estimated using Cox proportional hazards regression models. During a median follow-up of 15.5 years, 845 CHD and 3,388 all-cause deaths occurred among 4,885 participants [2,568 women (55.7%); mean (S.D.) age, 66.4 (12.5) years], respectively. In the unadjusted model, B2M concentration was strongly linearly associated with CHD and all-cause mortality (p-trend < 0.001). After adjusting multivariable factors, a positive linear association between B2M and all-cause mortality was still observed (H.R. for Q4 vs. Q1 5.90; 95% CI: 5.31–6.57; p-trend < 0.001). In the multivariable adjustment model, B2M was significantly associated with an increased risk of CHD mortality (H.R. for Q4 vs. Q1 2.72; 95% CI: 2.07–3.57; p-trend < 0.001). In the stratified analyses, the associations of B2M with CHD and all-cause mortality varied by risk factors, such as age, smoking status, and history of hypertension. The findings suggest a significant relationship between the higher serum B2M concentration and increased risk for CHD and all-cause mortality. Further large-scale follow-up studies are also needed to validate this association. Frontiers Media S.A. 2022-05-13 /pmc/articles/PMC9136227/ /pubmed/35647083 http://dx.doi.org/10.3389/fcvm.2022.834150 Text en Copyright © 2022 Huang, Lin, Zhai and Cheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Huang, Yangxi Lin, Yufeng Zhai, Xiaobing Cheng, Long Association of Beta-2-Microglobulin With Coronary Heart Disease and All-Cause Mortality in the United States General Population |
title | Association of Beta-2-Microglobulin With Coronary Heart Disease and All-Cause Mortality in the United States General Population |
title_full | Association of Beta-2-Microglobulin With Coronary Heart Disease and All-Cause Mortality in the United States General Population |
title_fullStr | Association of Beta-2-Microglobulin With Coronary Heart Disease and All-Cause Mortality in the United States General Population |
title_full_unstemmed | Association of Beta-2-Microglobulin With Coronary Heart Disease and All-Cause Mortality in the United States General Population |
title_short | Association of Beta-2-Microglobulin With Coronary Heart Disease and All-Cause Mortality in the United States General Population |
title_sort | association of beta-2-microglobulin with coronary heart disease and all-cause mortality in the united states general population |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136227/ https://www.ncbi.nlm.nih.gov/pubmed/35647083 http://dx.doi.org/10.3389/fcvm.2022.834150 |
work_keys_str_mv | AT huangyangxi associationofbeta2microglobulinwithcoronaryheartdiseaseandallcausemortalityintheunitedstatesgeneralpopulation AT linyufeng associationofbeta2microglobulinwithcoronaryheartdiseaseandallcausemortalityintheunitedstatesgeneralpopulation AT zhaixiaobing associationofbeta2microglobulinwithcoronaryheartdiseaseandallcausemortalityintheunitedstatesgeneralpopulation AT chenglong associationofbeta2microglobulinwithcoronaryheartdiseaseandallcausemortalityintheunitedstatesgeneralpopulation |